Genesis Private Wealth’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$702K Buy
585
+15
+3% +$15.3K 0.2% 74
2026
Q1
$524K Buy
570
+21
+4% +$21.3K 0.17% 85
2025
Q4
$590K Buy
549
+245
+81% +$234K 0.18% 79
2025
Q3
$232K Sell
304
-56
-16% -$41.7K 0.1% 129
2025
Q2
$281K Buy
360
+20
+6% +$15.5K 0.13% 100
2025
Q1
$281K Buy
340
+36
+12% +$30K 0.15% 92
2024
Q4
$235K Buy
+304
New +$252K 0.13% 110

Other funds holding LLY

Genesis Private Wealth's LLY Position: Q2 2026 in Review

Genesis Private Wealth increased its Eli Lilly (LLY) stake by 2.6% in Q2 2026, buying an estimated $15.3K and bringing the position to 585 shares worth $702K. The position accounts for 0.2% of the portfolio, ranked #74.

Genesis Private Wealth first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 1,102 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Genesis Private Wealth held 585 shares of Eli Lilly worth $702K as of Q2 2026.
  • Genesis Private Wealth bought 15 Eli Lilly shares in Q2 2026, an estimated $15.3K.
  • Eli Lilly made up 0.2% of Genesis Private Wealth's portfolio in Q2 2026, its #74 holding.
  • Genesis Private Wealth first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 1,102 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Genesis Private Wealth's 13F filing for Q2 2026, filed 13 Jul 2026.